Patents Assigned to TANDEM CO., LTD.
  • NOVEL RECOMBINANT EXOSOME AND USE THEREOF
    Publication number: 20210393736
    Abstract: Provided is a recombinant exosome, and more specifically, to a recombinant exosome obtained from a eukaryotic cell transfected for the expression of a glucose transporter protein (GLUT) and a membrane fusogenic protein, and use thereof.
    Type: Application
    Filed: September 3, 2021
    Publication date: December 23, 2021
    Applicant: TANDEM CO., LTD.
    Inventors: Yeon-Sun HONG, Yoo Soo YANG, Cherl Hyun JEONG, In-San KIM
  • NOVEL RECOMBINANT PLASMA MEMBRANE-BASED VESICLE, FOR TREATING CANCER
    Publication number: 20210106632
    Abstract: The present invention relates to a recombinant plasma membrane-based vesicle, and more specifically to a recombinant plasma membrane-based vesicle comprising a VSV-G mutated protein in which histidine, the 162nd amino acid, has been substituted with arginine, and a pharmaceutical composition for treating cancer comprising the recombinant plasma membrane-based vesicle.
    Type: Application
    Filed: September 28, 2018
    Publication date: April 15, 2021
    Applicant: TANDEM CO., LTD.
    Inventors: Gi-Beom KIM, Yoo Soo YANG, In-San KIM, Gihoon NAM